S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Stock market today: Asian shares mostly rise, lifted by bull market on Wall Street
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
6 Best Online and Direct Marketing Retail Stocks to Invest in
66,000% upside on tiny biotech? (Ad)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
US applications for jobless benefits highest since October 2021
S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Stock market today: Asian shares mostly rise, lifted by bull market on Wall Street
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
6 Best Online and Direct Marketing Retail Stocks to Invest in
66,000% upside on tiny biotech? (Ad)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
US applications for jobless benefits highest since October 2021
S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Stock market today: Asian shares mostly rise, lifted by bull market on Wall Street
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
6 Best Online and Direct Marketing Retail Stocks to Invest in
66,000% upside on tiny biotech? (Ad)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
US applications for jobless benefits highest since October 2021
S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Stock market today: Asian shares mostly rise, lifted by bull market on Wall Street
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
6 Best Online and Direct Marketing Retail Stocks to Invest in
66,000% upside on tiny biotech? (Ad)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
US applications for jobless benefits highest since October 2021
OTCMKTS:INLX

Intellinetics (INLX) Stock Forecast, Price & News

$3.46
-0.04 (-1.14%)
(As of 06/8/2023 ET)
Compare
Today's Range
$3.43
$3.50
50-Day Range
$3.46
$4.25
52-Week Range
$3.25
$11.94
Volume
1,501 shs
Average Volume
4,603 shs
Market Capitalization
$14.08 million
P/E Ratio
115.33
Dividend Yield
N/A
Price Target
N/A

INLX stock logo

About Intellinetics (OTCMKTS:INLX) Stock

Intellinetics, Inc. is a holding company, which engages in the provision of document services and software solutions to private and public sectors. It operates through the Document Management and Document Conversion segments. The Document Management segment allows customers to capture and manage all documents across operations. The Document Conversion segment assists clients as a part of overall document strategy to convert documents from one medium to another, predominantly paper to digital, including migration to software solutions. The company was founded by A. Michael Chretien, Matthew L. Chretien, and Thomas D. Moss on October 3, 1997 and is headquartered in Columbus, OH.

Receive INLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intellinetics and its competitors with MarketBeat's FREE daily newsletter.

INLX Stock News Headlines

This NASDAQ Stock Is The Amazon Of Medical Supply
This Little Known Company IS Quickly Becoming The Amazon Of Medical Supply. Learn More Now
Intellinetics Grows Revenues 55% in Q1 2023
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Intellinetics Grows Annual Revenue 22% in 2022
Here's what Wall Street expects from Intellinetics's earnings
Intellinetics Announces New Release of YellowFolder
See More Headlines

INLX Price History

INLX Company Calendar

Last Earnings
5/15/2023
Today
6/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
OTCMKTS:INLX
Fax
N/A
Employees
93
Year Founded
N/A

Profitability

Net Income
$20,000.00
Pretax Margin
1.01%

Debt

Sales & Book Value

Annual Sales
$14.02 million
Cash Flow
$0.25 per share
Book Value
$2.10 per share

Miscellaneous

Free Float
3,746,000
Market Cap
$14.08 million
Optionable
Not Optionable
Beta
0.38

Key Executives

  • James F. DeSocio
    President, Chief Executive Officer & Director
  • Mike Beck
    Vice President-Operations
  • Joe Spain
    Chief Financial Officer & Treasurer
  • Matt Chretien
    Secretary, Director, CTO & Chief Strategy Officer
  • Thomas D. Moss
    Vice President-Research & Development













INLX Stock - Frequently Asked Questions

Should I buy or sell Intellinetics stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Intellinetics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" INLX shares.
View INLX analyst ratings
or view top-rated stocks.

How have INLX shares performed in 2023?

Intellinetics' stock was trading at $4.27 at the beginning of the year. Since then, INLX stock has decreased by 19.0% and is now trading at $3.46.
View the best growth stocks for 2023 here
.

How were Intellinetics' earnings last quarter?

Intellinetics, Inc. (OTCMKTS:INLX) released its quarterly earnings data on Monday, May, 15th. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.01. The company had revenue of $4.19 million for the quarter, compared to the consensus estimate of $3.95 million. Intellinetics had a trailing twelve-month return on equity of 5.92% and a net margin of 1.02%.

What other stocks do shareholders of Intellinetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Intellinetics investors own include Co-Diagnostics (CODX), Tonix Pharmaceuticals (TNXP), Inovio Pharmaceuticals (INO), Kopin (KOPN), Onconova Therapeutics (ONTX), OPKO Health (OPK), Precipio (PRPO), Selecta Biosciences (SELB), Sierra Oncology (SRRA) and T2 Biosystems (TTOO).

What is Intellinetics' stock symbol?

Intellinetics trades on the OTCMKTS under the ticker symbol "INLX."

Who are Intellinetics' major shareholders?

Intellinetics' stock is owned by a number of retail and institutional investors. Top institutional investors include Susquehanna International Group LLP (0.43%).
View institutional ownership trends
.

How do I buy shares of Intellinetics?

Shares of INLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Intellinetics' stock price today?

One share of INLX stock can currently be purchased for approximately $3.46.

How much money does Intellinetics make?

Intellinetics (OTCMKTS:INLX) has a market capitalization of $14.08 million and generates $14.02 million in revenue each year. The company earns $20,000.00 in net income (profit) each year or $0.03 on an earnings per share basis.

How can I contact Intellinetics?

Intellinetics' mailing address is 2190 DIVIDEND DRIVE, COLUMBUS OH, 43228. The official website for the company is www.intellinetics.com. The company can be reached via phone at (614) 921-8170 or via email at contactus@intellinetics.com.

This page (OTCMKTS:INLX) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -